Use of NovoSeven® for arsenic trioxide-induced bleeding in PML [1]

American Journal of Hematology

Volumn 81, Issue 9, 2006, Pages 720-

  Alimoghaddam, Kamran ^a   Ghavamzadeh, Ardeshir ^a   Jahani, Mohamad ^a  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

ARSENIC TRIOXIDE; DEXAMETHASONE; RECOMBINANT BLOOD CLOTTING FACTOR 7A; RETINOIC ACID; ANTINEOPLASTIC AGENT; BLOOD CLOTTING FACTOR 7; ORGANOARSENIC DERIVATIVE; OXIDE; RECOMBINANT FVIIA; RECOMBINANT PROTEIN;

ADULT RESPIRATORY DISTRESS SYNDROME; CLINICAL ARTICLE; DISSEMINATED INTRAVASCULAR CLOTTING; DRUG INDUCED DISEASE; HUMAN; LETTER; LUNG HEMORRHAGE; PRIORITY JOURNAL; PROMYELOCYTIC LEUKEMIA; REMISSION; RETINOIC ACID SYNDROME; TREATMENT RESPONSE; BLEEDING; CHEMICALLY INDUCED DISORDER; LUNG DISEASE;

ANTINEOPLASTIC AGENTS; ARSENICALS; FACTOR VII; HEMORRHAGE; HUMANS; LEUKEMIA, PROMYELOCYTIC, ACUTE; LUNG DISEASES; OXIDES; RECOMBINANT PROTEINS;

EID: 33748103392     PISSN: 03618609     EISSN: 10968652     Source Type: Journal    
DOI: 10.1002/ajh.20713     Document Type: Letter

References (3)

1. Soigent S, Maslak P, Wang Z, et al. Complete remission after treatment of acute promyelocytic leukemia with arsenic trioxide. N Engl J Med 1998;339:1341-1348.
2. Tallam M, Nabahan C, Feusner H, et al. Acute promyelocytic leukemia: Evolving therapeutic strategies. Blood 2002:759-767.
3. Ghavamadeh A, Alimoghaddam K, Ghafari H, et al. Treatment of new cases of acute promyelocytic leukemia by arsenic trioxide. Blood 2004;104:11:116a.